Role of stem cell proteins and microRNAs in embryogenesis and germ cell cancer

International Journal of Developmental Biology

Volumn 57, Issue 2-4, 2013, Pages 319-332

  Eini, Ronak ^a   Dorssers, Lambert C J ^a   Looijenga, Leendert H J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Embryogenesis; Embryonic stem cell; Germ cell cancer; MicroRNA

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CELL PROTEIN; CISPLATIN; MESSENGER RNA PRECURSOR; MICRORNA; PLATINUM; SMALL UNTRANSLATED RNA; STEM CELL PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BASE PAIRING; BLASTOCYST; BODY FLUID; CANCER DIAGNOSIS; CANCER GROWTH; CANCER INHIBITION; CANCER PROGNOSIS; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; DEVELOPMENT; DRUG SENSITIVITY; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE SILENCING; GERM CELL TUMOR; HUMAN; HUMAN GENOME; INNER CELL MASS; METASTASIS; NEOPLASM; NONHUMAN; PLURIPOTENT STEM CELL; PRIMORDIAL GERM CELL; PRIORITY JOURNAL; TISSUE SPECIFICITY; TOTIPOTENT STEM CELL; TUMOR INVASION;

ANIMALS; CELL DIFFERENTIATION; EMBRYONIC DEVELOPMENT; EMBRYONIC STEM CELLS; GENE EXPRESSION REGULATION; GERM CELLS; HUMANS; MICRORNAS; NEOPLASMS, GERM CELL AND EMBRYONAL;

EID: 84880050395     PISSN: 02146282     EISSN: None     Source Type: Journal    
DOI: 10.1387/ijdb.130020re     Document Type: Article

References (121)

1. AKIMOTO, C., UEDA, T., INOUE, K., YAMAOKA, I., SAKARI, M., OBARA, W., FUJIOKA, T., NAGAHARA, A., NONOMURA, N., TSUTSUMI, S. et al., (2010). Testis-specific protein on Y chromosome (TSPY) represses the activity of the androgen receptor in androgen-dependent testicular germ-cell tumors. Proc Natl Acad Sci USA 107: 19891-19896.
2. ALVAREZ-GARCIA, I. and MISKA, E.A. (2005). MicroRNA functions in animal devel-opment and human disease. Development 132: 4653-4662.
3. ANOKYE-DANSO, F., TRIVEDI, C.M., JUHR, D., GUPTA, M., CUI, Z., TIAN, Y., ZHANG, Y., YANG, W., GRUBER, P.J., EPSTEIN, J.A. et al., (2011). Highly ef-ficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell 8: 376-388.
4. ARROYO, J.D., CHEVILLET, J.R., KROH, E.M., RUF, I.K., PRITCHARD, C.C., GIBSON, D.F., MITCHELL, P.S., BENNETT, C.F., POGOSOVA-AGADJANYAN, E.L., STIREWALT, D.L. et al., (2011). Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA 108: 5003-5008.
5. BARROSO-DELJESUS, A., ROMERO-LOPEZ, C., LUCENA-AGUILAR, G., MELEN, G.J., SANCHEZ, L., LIGERO, G., BERZAL-HERRANZ, A. and MENENDEZ, P. (2008). Embryonic stem cell-specific miR302-367 cluster: human gene structure and functional characterization of its core promoter. Mol Cell Biol 28: 6609-6619.
6. BAYLIN, S.B., ESTELLER, M., ROUNTREE, M.R., BACHMAN, K.E., SCHUEBEL, K. and HERMAN, J.G. (2001). Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum Mol Genet 10: 687-692.
7. BEILLARD, E., ONG, S.C., GIANNAKAKIS, A., GUCCIONE, E., VARDY, L.A. and VOORHOEVE, P.M. (2012). miR-Sens--a retroviral dual-luciferase reporter to detect microRNA activity in primary cells. RNA 18: 1091-1100.
8. BELGE, G., DIECKMANN, K.P., SPIEKERMANN, M., BALKS, T. and BULLERDIEK, J. (2012). Serum levels of microRNAs miR-371-3: a novel class of serum biomarkers for testicular germ cell tumors? Eur Urol 61: 1068-1069.
9. BERNSTEIN, E., KIM, S.Y., CARMELL, M.A., MURCHISON, E.P., ALCORN, H., LI, M.Z., MILLS, A.A., ELLEDGE, S.J., ANDERSON, K.V. and HANNON, G.J. (2003). Dicer is essential for mouse development. Nat Genet 35: 215-217.
10. BOIANI, M., KEHLER, J. and SCHOLER, H.R. (2004). Activity of the germline-specific Oct4-GFP transgene in normal and clone mouse embryos. Methods Mol Biol 254: 1-34.
11. BOYER, L.A., LEE, T.I., COLE, M.F., JOHNSTONE, S.E., LEVINE, S.S., ZUCKER, J.P., GUENTHER, M.G., KUMAR, R.M., MURRAY, H.L., JENNER, R.G. et al., (2005). Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122: 947-956.
12. CAIRO, S., WANG, Y., DE REYNIES, A., DUROURE, K., DAHAN, J., REDON, M.J., FABRE, M., MCCLELLAND, M., WANG, X.W., CROCE, C.M. et al., (2010). Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer. Proc Natl Acad Sci USA 107: 20471-20476.
13. CALABRESE, J.M., SEILA, A.C., YEO, G.W. and SHARP, P.A. (2007). RNA sequence analysis defines Dicer's role in mouse embryonic stem cells. Proc Natl Acad Sci USA 104: 18097-18102.
14. CAMPAYO, M., NAVARRO, A., VINOLAS, N., DIAZ, T., TEJERO, R., GIMFERRER, J.M., MOLINS, L., CABANAS, M.L., RAMIREZ, J., MONZO, M. et al., (2013). Low miR-145 and high miR-367 are associated with unfavorable prognosis in resected NSCLC. 41: 1172-1178.
15. CANELA, N., RODRIGUEZ-VILARRUPLA, A., ESTANYOL, J.M., DIAZ, C., PUJOL, M.J., AGELL, N. and BACHS, O. (2003). The SET protein regulates G2/M transi-tion by modulating cyclin B-cyclin-dependent kinase 1 activity. J Biol Chem 278: 1158-1164.
16. CARD, D.A., HEBBAR, P.B., LI, L., TROTTER, K.W., KOMATSU, Y., MISHINA, Y. and ARCHER, T.K. (2008). Oct4/Sox2-regulated miR-302 targets cyclin D1 in human embryonic stem cells. Mol Cell Biol 28: 6426-6438.
17. CHEN, C.Z. (2005). MicroRNAs as oncogenes and tumor suppressors. N Engl J Med 353: 1768-1771.
18. CHEN, X., BA, Y., MA, L., CAI, X., YIN, Y., WANG, K., GUO, J., ZHANG, Y., CHEN, J., GUO, X. et al., (2008). Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18: 997-1006.
19. DE JONG, J., STOOP, H., GILLIS, A.J., VAN GURP, R.J., VAN DE GEIJN, G.J., BOER, M., HERSMUS, R., SAUNDERS, P.T., ANDERSON, R.A., OOSTERHUIS, J.W. et al., (2008). Differential expression of SOX17 and SOX2 in germ cells and stem cells has biological and clinical implications. J Pathol 215: 21-30.
20. FAREH, M., TURCHI, L., VIROLLE, V., DEBRUYNE, D., ALMAIRAC, F., DE-LA-FOREST DIVONNE, S., PAQUIS, P., PREYNAT-SEAUVE, O., KRAUSE, K.H., CHNEIWEISS, H. et al., (2012). The miR 302-367 cluster drastically affects self-renewal and infiltration properties of glioma-initiating cells through CXCR4 repression and consequent disruption of the SHH-GLI-NANOG network. Cell Death Differ 19: 232-244.
21. GALLO, A., TANDON, M., ALEVIZOS, I. and ILLEI, G.G. (2012). The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS One 7: e30679.
22. GILLIS, A.J., STOOP, H.J., HERSMUS, R., OOSTERHUIS, J.W., SUN, Y., CHEN, C., GUENTHER, S., SHERLOCK, J., VELTMAN, I., BAETEN, J. et al., (2007). High-throughput microRNAome analysis in human germ cell tumours. J Pathol 213: 319-328.
23. HAJKOVA, P., ERHARDT, S., LANE, N., HAAF, T., EL-MAARRI, O., REIK, W., WAL-TER, J. and SURANI, M.A. (2002). Epigenetic reprogramming in mouse primordial germ cells. Mech Dev 117: 15-23.
24. HANAHAN, D. and WEINBERG, R.A. (2000). The hallmarks of cancer. Cell 100: 57-70.
25. HE, S., NAKADA, D. and MORRISON, S.J. (2009). Mechanisms of stem cell self-renewal. Annu Rev Cell Dev Biol 25: 377-406.
26. HOLM, T.M., JACKSON-GRUSBY, L., BRAMBRINK, T., YAMADA, Y., RIDEOUT, W.M., 3RD and JAENISCH, R. (2005). Global loss of imprinting leads to widespread tumorigenesis in adult mice. Cancer Cell 8: 275-285.
27. HONG, Y. and STAMBROOK, P.J. (2004). Restoration of an absent G1 arrest and protection from apoptosis in embryonic stem cells after ionizing radiation. Proc Natl Acad Sci USA 101: 14443-14448.
28. HORWICH, A., SHIPLEY, J. and HUDDART, R. (2006). Testicular germ-cell cancer. Lancet 367: 754-765.
29. HUANG, Q., GUMIREDDY, K., SCHRIER, M., LE SAGE, C., NAGEL, R., NAIR, S., EGAN, D.A., LI, A., HUANG, G., KLEIN-SZANTO, A.J. et al., (2008). The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol 10: 202-210.
30. HUANGFU, D., MAEHR, R., GUO, W., EIJKELENBOOM, A., SNITOW, M., CHEN, A.E. and MELTON, D.A. (2008). Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat Biotechnol 26: 795-797.
31. HURTEAU, G.J., CARLSON, J.A., SPIVACK, S.D. and BROCK, G.J. (2007). Overex-pression of the microRNA hsa-miR-200c leads to reduced expression of transcrip-tion factor 8 and increased expression of E-cadherin. Cancer Res 67: 7972-7976.
32. HUYGHE, E., PLANTE, P. and THONNEAU, P.F. (2007). Testicular cancer variations in time and space in Europe. Eur Urol 51: 621-628.
33. JAENISCH, R. and YOUNG, R. (2008). Stem cells, the molecular circuitry of pluri-potency and nuclear reprogramming. Cell 132: 567-582.
34. JUDSON, R.L., BABIARZ, J.E., VENERE, M. and BLELLOCH, R. (2009). Embryonic stem cell-specific microRNAs promote induced pluripotency. Nat Biotechnol 27: 459-461.
35. KANAI-AZUMA, M., KANAI, Y., GAD, J.M., TAJIMA, Y., TAYA, C., KUROHMARU, M., SANAI, Y., YONEKAWA, H., YAZAKI, K., TAM, P.P. et al., (2002). Depletion of definitive gut endoderm in Sox17-null mutant mice. Development 129: 2367-2379.
36. KANELLOPOULOU, C., MULJO, S.A., KUNG, A.L., GANESAN, S., DRAPKIN, R., JENUWEIN, T., LIVINGSTON, D.M. and RAJEWSKY, K. (2005). Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing. Genes Dev 19: 489-501.
37. KARP, X. and AMBROS, V. (2005). Developmental biology. Encountering microRNAs in cell fate signaling. Science 310: 1288-1289.
38. KERSEMAEKERS, A.M., MAYER, F., MOLIER, M., VAN WEEREN, P.C., OOSTER-HUIS, J.W., BOKEMEYER, C. and LOOIJENGA, L.H. (2002). Role of P53 and MDM2 in treatment response of human germ cell tumors. J Clin Oncol 20: 1551-1561.
39. KORKOLA, J.E., HOULDSWORTH, J., CHADALAVADA, R.S., OLSHEN, A.B., DOBRZYNSKI, D., REUTER, V.E., BOSL, G.J. and CHAGANTI, R.S. (2006). Down-regulation of stem cell genes, including those in a 200-kb gene cluster at 12p13.31, is associated with in vivo differentiation of human male germ cell tumors. Cancer Res 66: 820-827.
40. KUCKENBERG, P., PEITZ, M., KUBACZKA, C., BECKER, A., EGERT, A., WARDEL-MANN, E., ZIMMER, A., BRUSTLE, O. and SCHORLE, H. (2011). Lineage conversion of murine extraembryonic trophoblast stem cells to pluripotent stem cells. Mol Cell Biol 31: 1748-1756.
41. LANDTHALER, M., YALCIN, A. and TUSCHL, T. (2004). The human DiGeorge syndrome critical region gene 8 and Its D. melanogaster homolog are required for miRNA biogenesis. Curr Biol 14: 2162-2167.
42. LAWRIE, C.H., CHI, J., TAYLOR, S., TRAMONTI, D., BALLABIO, E., PALAZZO, S., SAUNDERS, N.J., PEZZELLA, F., BOULTWOOD, J., WAINSCOAT, J.S. et al., (2009). Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma. J Cell Mol Med 13: 1248-1260.
43. LEE, K.H., GOAN, Y.G., HSIAO, M., LEE, C.H., JIAN, S.H., LIN, J.T., CHEN, Y.L. and LU, P.J. (2009). MicroRNA-373 (miR-373) post-transcriptionally regulates large tumor suppressor, homolog 2 (LATS2) and stimulates proliferation in human esophageal cancer. Exp Cell Res 315: 2529-2538.
44. LEE, R.C., FEINBAUM, R.L. and AMBROS, V. (1993). The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75: 843-854.
45. LEE, Y., AHN, C., HAN, J., CHOI, H., KIM, J., YIM, J., LEE, J., PROVOST, P., RAD-MARK, O., KIM, S. et al., (2003). The nuclear RNase III Drosha initiates microRNA processing. Nature 425: 415-419.
46. LIM, L.P., LAU, N.C., WEINSTEIN, E.G., ABDELHAKIM, A., YEKTA, S., RHOADES, M.W., BURGE, C.B. and BARTEL, D.P. (2003). The microRNAs of Caenorhabditis elegans. Genes Dev 17: 991-1008.
47. LIN, S.L., CHANG, D.C., CHANG-LIN, S., LIN, C.H., WU, D.T., CHEN, D.T. and YING, S.Y. (2008). Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state. RNA 14: 2115-2124.
48. LIU, C., KELNAR, K., LIU, B., CHEN, X., CALHOUN-DAVIS, T., LI, H., PATRAWALA, L., YAN, H., JETER, C., HONORIO, S. et al., (2011). The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med 17: 211-215.
49. LIU, C. and TANG, D.G. (2011). MicroRNA regulation of cancer stem cells. Cancer Res 71: 5950-5954.
50. LOH, Y.H., WU, Q., CHEW, J.L., VEGA, V.B., ZHANG, W., CHEN, X., BOURQUE, G., GEORGE, J., LEONG, B., LIU, J. et al., (2006). The Oct4 and Nanog tran-scription network regulates pluripotency in mouse embryonic stem cells. Nat Genet 38: 431-440.
51. LOOIJENGA, L.H., GILLIS, A.J., STOOP, H., HERSMUS, R. and OOSTERHUIS, J.W. (2007). Relevance of microRNAs in normal and malignant development, including human testicular germ cell tumours. Int J Androl 30: 304-314; discussion 314-315.
52. LOOIJENGA, L.H., HERSMUS, R., GILLIS, A.J., PFUNDT, R., STOOP, H.J., VAN GURP, R.J., VELTMAN, J., BEVERLOO, H.B., VAN DRUNEN, E., VAN KESSEL, A.G. et al., (2006). Genomic and expression profiling of human spermatocytic seminomas: primary spermatocyte as tumorigenic precursor and DMRT1 as candidate chromosome 9 gene. Cancer Res 66: 290-302.
53. LOOIJENGA, L.H., STOOP, H., DE LEEUW, H.P., DE GOUVEIA BRAZAO, C.A., GILLIS, A.J., VAN ROOZENDAAL, K.E., VAN ZOELEN, E.J., WEBER, R.F., WOLFFENBUTTEL, K.P., VAN DEKKEN, H. et al., (2003). POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res 63: 2244-2250.
54. LU, R., MARKOWETZ, F., UNWIN, R.D., LEEK, J.T., AIROLDI, E.M., MACARTHUR, B.D., LACHMANN, A., ROZOV, R., MA'AYAN, A., BOYER, L.A. et al., (2009). Systems-level dynamic analyses of fate change in murine embryonic stem cells. Nature 462: 358-362.
55. LUJAMBIO, A., CALIN, G.A., VILLANUEVA, A., ROPERO, S., SANCHEZ-CESPEDES, M., BLANCO, D., MONTUENGA, L.M., ROSSI, S., NICOLOSO, M.S., FALLER, W.J. et al., (2008). A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci USA 105: 13556-13561.
56. LUND, E., GUTTINGER, S., CALADO, A., DAHLBERG, J.E. and KUTAY, U. (2004). Nuclear export of microRNA precursors. Science 303: 95-98.
57. MARSON, A., LEVINE, S.S., COLE, M.F., FRAMPTON, G.M., BRAMBRINK, T., JOHNSTONE, S., GUENTHER, M.G., JOHNSTON, W.K., WERNIG, M., NEW-MAN, J. et al., (2008). Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell 134: 521-533.
58. MASTERS, J.R. and KOBERLE, B. (2003). Curing metastatic cancer: lessons from testicular germ-cell tumours. Nat Rev Cancer 3: 517-525.
59. MASUI, S., NAKATAKE, Y., TOYOOKA, Y., SHIMOSATO, D., YAGI, R., TAKAHASHI, K., OKOCHI, H., OKUDA, A., MATOBA, R., SHAROV, A.A. et al., (2007). Pluripo-tency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat Cell Biol 9: 625-635.
60. MCIVER, S.C., STANGER, S.J., SANTARELLI, D.M., ROMAN, S.D., NIXON, B. and MCLAUGHLIN, E.A. (2012). A unique combination of male germ cell miRNAs coordinates gonocyte differentiation. PLoS One 7: e35553.
61. MCLAREN, A. (2003). Primordial germ cells in the mouse. Dev Biol 262: 1-15.
62. MEDEIROS, L.A., DENNIS, L.M., GILL, M.E., HOUBAVIY, H., MARKOULAKI, S., FU, D., WHITE, A.C., KIRAK, O., SHARP, P.A., PAGE, D.C. et al., (2011). Mir-290-295 deficiency in mice results in partially penetrant embryonic lethality and germ cell defects. Proc Natl Acad Sci USA 108: 14163-14168.
63. MELTON, C., JUDSON, R.L. and BLELLOCH, R. (2010). Opposing microRNA fami-lies regulate self-renewal in mouse embryonic stem cells. Nature 463: 621-626.
64. MESTDAGH, P., VAN VLIERBERGHE, P., DE WEER, A., MUTH, D., WESTERMANN, F., SPELEMAN, F. and VANDESOMPELE, J. (2009). A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol 10: R64.
65. MINENO, J., OKAMOTO, S., ANDO, T., SATO, M., CHONO, H., IZU, H., TAKAYAMA, M., ASADA, K., MIROCHNITCHENKO, O., INOUYE, M. et al., (2006). The expres-sion profile of microRNAs in mouse embryos. Nucleic Acids Res 34: 1765-1771.
66. MITSUI, K., TOKUZAWA, Y., ITOH, H., SEGAWA, K., MURAKAMI, M., TAKAHASHI, K., MARUYAMA, M., MAEDA, M. and YAMANAKA, S. (2003). The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113: 631-642.
67. MIYOSHI, N., ISHII, H., NAGANO, H., HARAGUCHI, N., DEWI, D.L., KANO, Y., NISHIKAWA, S., TANEMURA, M., MIMORI, K., TANAKA, F. et al., (2011). Repro-gramming of mouse and human cells to pluripotency using mature microRNAs. Cell Stem Cell 8: 633-638.
68. MORA, P.T., CHANDRASEKARAN, K. and MCFARLAND, V.W. (1980). An embryo protein induced by SV40 virus transformation of mouse cells. Nature 288: 722-724.
69. MORIMURA, R., KOMATSU, S., ICHIKAWA, D., TAKESHITA, H., TSUJIURA, M., NAGATA, H., KONISHI, H., SHIOZAKI, A., IKOMA, H., OKAMOTO, K. et al., (2011). Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer. Br J Cancer 105: 1733-1740.
70. MORIN, R.D., O'CONNOR, M.D., GRIFFITH, M., KUCHENBAUER, F., DELANEY, A., PRABHU, A.L., ZHAO, Y., MCDONALD, H., ZENG, T., HIRST, M. et al., (2008). Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells. Genome Res 18: 610-621.
71. MURRAY, M.J. and COLEMAN, N. (2012). Testicular cancer: a new generation of biomarkers for malignant germ cell tumours. Nat Rev Urol 9: 298-300.
72. MURRAY, M.J., HALSALL, D.J., HOOK, C.E., WILLIAMS, D.M., NICHOLSON, J.C. and COLEMAN, N. (2011). Identification of microRNAs From the miR-371~373 and miR-302 clusters as potential serum biomarkers of malignant germ cell tumors. Am J Clin Pathol 135: 119-125.
73. NAKAGAWA, M., KOYANAGI, M., TANABE, K., TAKAHASHI, K., ICHISAKA, T., AOI, T., OKITA, K., MOCHIDUKI, Y., TAKIZAWA, N. and YAMANAKA, S. (2008). Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 26: 101-106.
74. NEGRINI, M. and CALIN, G.A. (2008). Breast cancer metastasis: a microRNA story. Breast Cancer Res 10: 203.
75. NOVOTNY, G.W., BELLING, K.C., BRAMSEN, J.B., NIELSEN, J.E., BORK-JENSEN, J., ALMSTRUP, K., SONNE, S.B., KJEMS, J., RAJPERT-DE MEYTS, E. and LEFFERS, H. (2012). MicroRNA expression profiling of carcinoma in situ cells of the testis. Endocr Relat Cancer 19: 365-379.
76. OOSTERHUIS, J.W. and LOOIJENGA, L.H. (2005). Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer 5: 210-222.
77. ORAM, S.W., LIU, X.X., LEE, T.L., CHAN, W.Y. and LAU, Y.F. (2006). TSPY potenti-ates cell proliferation and tumorigenesis by promoting cell cycle progression in HeLa and NIH3T3 cells. BMC Cancer 6: 154.
78. OVITT, C.E. and SCHOLER, H.R. (1998). The molecular biology of Oct-4 in the early mouse embryo. Mol Hum Reprod 4: 1021-1031.
79. PAGE, D.C. (1987). Hypothesis: a Y-chromosomal gene causes gonadoblastoma in dysgenetic gonads. Development 101 Suppl: 151-155.
80. PAN, G. and THOMSON, J.A. (2007). Nanog and transcriptional networks in embryonic stem cell pluripotency. Cell Res 17: 42-49.
81. PERRETT, R.M., TURNPENNY, L., ECKERT, J.J., O'SHEA, M., SONNE, S.B., CAMERON, I.T., WILSON, D.I., RAJPERT-DE MEYTS, E. and HANLEY, N.A. (2008). The early human germ cell lineage does not express SOX2 during in vivo development or upon in vitro culture. Biol Reprod 78: 852-858.
82. PESCE, M. and SCHOLER, H.R. (2001). Oct-4: gatekeeper in the beginnings of mammalian development. Stem Cells 19: 271-278.
83. PLASS, C. and SOLOWAY, P.D. (2002). DNA methylation, imprinting and cancer. Eur J Hum Genet 10: 6-16.
84. REINHART, B.J., SLACK, F.J., BASSON, M., PASQUINELLI, A.E., BETTINGER, J.C., ROUGVIE, A.E., HORVITZ, H.R. and RUVKUN, G. (2000). The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403: 901-906.
85. REINHART, B.J., WEINSTEIN, E.G., RHOADES, M.W., BARTEL, B. and BARTEL, D.P. (2002). MicroRNAs in plants. Genes Dev 16: 1616-1626.
86. RIPPE, V., DITTBERNER, L., LORENZ, V.N., DRIESCHNER, N., NIMZYK, R., SENDT, W., JUNKER, K., BELGE, G. and BULLERDIEK, J. (2010). The two stem cell microRNA gene clusters C19MC and miR-371-3 are activated by specific chromo-somal rearrangements in a subgroup of thyroid adenomas. PLoS One 5: e9485.
87. ROSNER, M.H., VIGANO, M.A., OZATO, K., TIMMONS, P.M., POIRIER, F., RIGBY, P.W. and STAUDT, L.M. (1990). A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature 345: 686-692.
88. SABAPATHY, K., KLEMM, M., JAENISCH, R. and WAGNER, E.F. (1997). Regula-tion of ES cell differentiation by functional and conformational modulation of p53. EMBO J 16: 6217-6229.
89. SCHOLER, H.R., BALLING, R., HATZOPOULOS, A.K., SUZUKI, N. and GRUSS, P. (1989). Octamer binding proteins confer transcriptional activity in early mouse embryogenesis. EMBO J 8: 2551-2557.
90. SHAH, M.N., DEVESA, S.S., ZHU, K. and MCGLYNN, K.A. (2007). Trends in testicular germ cell tumours by ethnic group in the United States. Int J Androl 30: 206-13; discussion 213-214.
91. SHARMA, S., KELLY, T.K. and JONES, P.A. (2010). Epigenetics in cancer. Carci-nogenesis 31: 27-36.
92. SKAKKEBAEK, N.E. (1972). Possible carcinoma-in-situ of the testis. Lancet 2: 516-517.
93. SMIRAGLIA, D.J., SZYMANSKA, J., KRAGGERUD, S.M., LOTHE, R.A., PELTOMAKI, P. and PLASS, C. (2002). Distinct epigenetic phenotypes in seminomatous and nonseminomatous testicular germ cell tumors. Oncogene 21: 3909-3916.
94. SOLOZOBOVA, V. and BLATTNER, C. (2011). p53 in stem cells. World J Biol Chem 2: 202-14.
95. STADLER, B., IVANOVSKA, I., MEHTA, K., SONG, S., NELSON, A., TAN, Y., MA-THIEU, J., DARBY, C., BLAU, C.A., WARE, C. et al., (2010). Characterization of microRNAs involved in embryonic stem cell states. Stem Cells Dev 19: 935-950.
96. SUH, M.R., LEE, Y., KIM, J.Y., KIM, S.K., MOON, S.H., LEE, J.Y., CHA, K.Y., CHUNG, H.M., YOON, H.S., MOON, S.Y. et al., (2004). Human embryonic stem cells express a unique set of microRNAs. Dev Biol 270: 488-498.
97. TAKAHASHI, K. and YAMANAKA, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.
98. TOYOTA, M., SUZUKI, H., SASAKI, Y., MARUYAMA, R., IMAI, K., SHINOMURA, Y. and TOKINO, T. (2008). Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res 68: 4123-4132.
99. TREMBLAY, K.D., DUNN, N.R. and ROBERTSON, E.J. (2001). Mouse embryos lacking Smad1 signals display defects in extra-embryonic tissues and germ cell formation. Development 128: 3609-3621.
100. TURCHINOVICH, A., WEIZ, L., LANGHEINZ, A. and BURWINKEL, B. (2011). Charac-terization of extracellular circulating microRNA. Nucleic Acids Res 39: 7223-7233.
101. VAN DER ZWAN, Y.G., STOOP, H., ROSSELLO, F., WHITE, S.J. and LOOIJENGA, L.H.J. (2013). Role of epigenetics in the etiology of germ cell cancer. Int. J. Dev. Biol. 57: (doi: 10.1387/ijdb.130017ll).
102. VAN GURP, R.J., OOSTERHUIS, J.W., KALSCHEUER, V., MARIMAN, E.C. and LOOIJENGA, L.H. (1994). Biallelic expression of the H19 and IGF2 genes in human testicular germ cell tumors. J Natl Cancer Inst 86: 1070-1075.
103. VOORHOEVE, P.M., LE SAGE, C., SCHRIER, M., GILLIS, A.J., STOOP, H., NAGEL, R., LIU, Y.P., VAN DUIJSE, J., DROST, J., GRIEKSPOOR, A. et al., (2006). A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 124: 1169-1181.
104. WANG, K., ZHANG, S., WEBER, J., BAXTER, D. and GALAS, D.J. (2010). Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res 38: 7248-7259.
105. WANG, Y., BASKERVILLE, S., SHENOY, A., BABIARZ, J.E., BAEHNER, L. and BLELLOCH, R. (2008). Embryonic stem cell-specific microRNAs regulate the G1-S transition and promote rapid proliferation. Nat Genet 40: 1478-1483.
106. WANG, Y., KEYS, D.N., AU-YOUNG, J.K. and CHEN, C. (2009). MicroRNAs in embryonic stem cells. J Cell Physiol 218: 251-255.
107. WANG, Y., MEDVID, R., MELTON, C., JAENISCH, R. and BLELLOCH, R. (2007). DGCR8 is essential for microRNA biogenesis and silencing of embryonic stem cell self-renewal. Nat Genet 39: 380-385.
108. WATANABE, T., TAKEDA, A., MISE, K., OKUNO, T., SUZUKI, T., MINAMI, N. and IMAI, H. (2005). Stage-specific expression of microRNAs during Xenopus devel-opment. FEBS Lett 579: 318-324.
109. WERNIG, M., MEISSNER, A., CASSADY, J.P. and JAENISCH, R. (2008). c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell 2: 10-12.
110. WHITE, J., STEAD, E., FAAST, R., CONN, S., CARTWRIGHT, P. and DALTON, S. (2005). Developmental activation of the Rb-E2F pathway and establishment of cell cycle-regulated cyclin-dependent kinase activity during embryonic stem cell differentiation. Mol Biol Cell 16: 2018-2027.
111. WIENHOLDS, E. and PLASTERK, R.H. (2005). MicroRNA function in animal develop-ment. FEBS Lett 579: 5911-5922.
112. WILLIAMS, C.J. and WHITEHOUSE, J.M. (1979). Cis-platinum: a new anticancer agent. Br Med J 1: 1689-1691.
113. WU, N., LIU, X., XU, X., FAN, X., LIU, M., LI, X., ZHONG, Q. and TANG, H. (2011). MicroRNA-373, a new regulator of protein phosphatase 6, functions as an onco-gene in hepatocellular carcinoma. FEBS J 278: 2044-2054.
114. YAMAGUCHI, S., KURIMOTO, K., YABUTA, Y., SASAKI, H., NAKATSUJI, N., SAITOU, M. and TADA, T. (2009). Conditional knockdown of Nanog induces apoptotic cell death in mouse migrating primordial germ cells. Development 136: 4011-4020.
115. YANG, K., HANDOREAN, A.M. and ICZKOWSKI, K.A. (2009). MicroRNAs 373 and 520c are downregulated in prostate cancer, suppress CD44 translation and en-hance invasion of prostate cancer cells in vitro. Int J Clin Exp Pathol 2: 361-369.
116. YU, J., WANG, F., YANG, G.H., WANG, F.L., MA, Y.N., DU, Z.W. and ZHANG, J.W. (2006). Human microRNA clusters: genomic organization and expression profilein leukemia cell lines. Biochem Biophys Res Commun 349: 59-68.
117. ZAHM, A.M., THAYU, M., HAND, N.J., HORNER, A., LEONARD, M.B. and FRIED-MAN, J.R. (2011). Circulating microRNA is a biomarker of pediatric Crohn disease. J Pediatr Gastroenterol Nutr 53: 26-33.
118. ZHAO, J.J., YANG, J., LIN, J., YAO, N., ZHU, Y., ZHENG, J., XU, J., CHENG, J.Q., LIN, J.Y. and MA, X. (2009). Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysis. Childs Nerv Syst 25: 13-20.
119. ZHAO, Y., YIN, X., QIN, H., ZHU, F., LIU, H., YANG, W., ZHANG, Q., XIANG, C., HOU, P., SONG, Z. et al., (2008). Two supporting factors greatly improve the efficiency of human iPSC generation. Cell Stem Cell 3: 475-479.
120. ZHENG, G.X., RAVI, A., CALABRESE, J.M., MEDEIROS, L.A., KIRAK, O., DENNIS, L.M., JAENISCH, R., BURGE, C.B. and SHARP, P.A. (2011). A latent pro-survival function for the mir-290-295 cluster in mouse embryonic stem cells. PLoS Genet 7: e1002054.
121. ZILIAK, D., GAMAZON, E.R., LACROIX, B., KYUNG IM, H., WEN, Y. and HUANG, R.S. (2012). Genetic variation that predicts platinum sensitivity reveals the role of miR-193b* in chemotherapeutic susceptibility. Mol Cancer Ther 11: 2054-2061.